LifeStance Health Group, Inc. (NASDAQ:LFST) Insider Lisa K. Miller Sells 18,845 Shares

LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) insider Lisa K. Miller sold 18,845 shares of the firm's stock in a transaction on Monday, March 17th. The shares were sold at an average price of $6.90, for a total value of $130,030.50. Following the completion of the sale, the insider now owns 339,810 shares in the company, valued at approximately $2,344,689. This represents a 5.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

LifeStance Health Group Stock Performance

LifeStance Health Group stock traded up $0.03 during mid-day trading on Friday, reaching $6.85. 3,135,738 shares of the company were exchanged, compared to its average volume of 1,514,969. The firm's 50-day simple moving average is $7.72 and its two-hundred day simple moving average is $7.35. LifeStance Health Group, Inc. has a twelve month low of $4.64 and a twelve month high of $8.61. The firm has a market cap of $2.63 billion, a PE ratio of -26.35 and a beta of 1.27. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on LFST. The Goldman Sachs Group upgraded LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $10.00 price objective for the company in a research note on Monday, December 16th. William Blair reiterated an "outperform" rating on shares of LifeStance Health Group in a research report on Friday, February 28th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $8.63.

Remove Ads

Hedge Funds Weigh In On LifeStance Health Group

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Blue Trust Inc. lifted its stake in shares of LifeStance Health Group by 124.4% in the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company's stock worth $27,000 after acquiring an additional 2,122 shares during the period. LPL Financial LLC raised its holdings in LifeStance Health Group by 6.0% during the fourth quarter. LPL Financial LLC now owns 37,584 shares of the company's stock worth $277,000 after purchasing an additional 2,127 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in LifeStance Health Group by 2.4% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 138,781 shares of the company's stock valued at $1,023,000 after purchasing an additional 3,305 shares during the period. MetLife Investment Management LLC boosted its holdings in LifeStance Health Group by 6.8% in the 4th quarter. MetLife Investment Management LLC now owns 85,914 shares of the company's stock valued at $633,000 after purchasing an additional 5,492 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its position in LifeStance Health Group by 31.4% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,105 shares of the company's stock worth $169,000 after purchasing an additional 5,767 shares during the period. 85.50% of the stock is currently owned by hedge funds and other institutional investors.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.